Flexible liquid crystal polymer-based electrochemical sensor for in-situ detection of zinc(II) in seawater

This is a post-peer-review, pre-copyedit version of an article published in 'Flexible liquid crystal polymer-based electrochemical sensor for in-situ detection of zinc(II) in seawater'. The final authenticated version is available online at: 10.1007/s00604-017-2280-

Determination of Trace Bismuth by Under-Potential Deposition-Stripping Voltammetry at Mesoporous Platinum Microelectrodes: Application to Pharmaceutical Products

A methodology for the determination of bismuth, based on under-potential deposition-stripping voltammetry (UPD-SV), was investigated. It makes use of mesoporous platinum microelectrodes (Pt-MEs) prepared by a liquid crystal templating technique. The mesoporous microelectrodes, which are characterised by a very high surface area, allowed the accumulation of relatively large amounts of bismuth at under-potential without saturation of the electrode surface. Calibration plots for quantification of bismuth at micromolar levels were constructed by using the charge involved in either the anodic or cathodic peak recoded by cyclic voltammetry that ensued the accumulation of bismuth at the electrode surface. During the anodic scan, the oxidation of metallic bismuth occurred; the cathodic scan involved irreversibly adsorbed bismuth species, which are retained on to the electrode surface. The reproducibility of the proposed UPD-SV procedure (which was within 5 %) was assured by the application to the Pt-MEs of a suitable potential waveform, properly designed to avoid memory effect due to the irreversibly deposited bismuth. The latter phenomenon along with UPD allowed to overcome interference due to copper, which is normally observed when quantification of bismuth is performed by anodic stripping voltammetry at solid electrodes involving bulk metal deposits. The usefulness of the proposed method for the determination of bismuth in real samples was demonstrated by the analysis of a tablet of a pharmaceutical preparation, which is used for curing ulcers

Hormonal Induction and Roles of Disabled-2 in Lactation and Involution

Disabled-2 (Dab2) is a widely expressed endocytic adaptor that was first isolated as a 96 KDa phospho-protein, p96, involved in MAPK signal transduction. Dab2 expression is lost in several cancer types including breast cancer, and Dab2 is thought to have a tumor suppressor function. In mammary epithelia, Dab2 was induced upon pregnancy and further elevated during lactation. We constructed mutant mice with a mosaic Dab2 gene deletion to bypass early embryonic lethality and to investigate the roles of Dab2 in mammary physiology. Loss of Dab2 had subtle effects on lactation, but Dab2-deficient mammary glands showed a strikingly delayed cell clearance during involution. In primary cultures of mouse mammary epithelial cells, Dab2 proteins were also induced by estrogen, progesterone, and/or prolactin. Dab2 null mammary epithelial cells were refractory to growth suppression induced by TGF-beta. However, Dab2 deletion did not affect Smad2 phosphorylation; rather TGF-beta-stimulated MAPK activation was enhanced in Dab2-deficient cells. We conclude that Dab2 expression is induced by hormones and Dab2 plays a role in modulating TGF-beta signaling to enhance apoptotic clearance of mammary epithelial cells during involution

[18F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level

PURPOSE: The aim of the study was to investigate the relationship between [F]fluoromethyl-dimethyl-2-hydroxyethylammonium ([F]FCh) positron emission tomography (PET) parameters, laboratory parameters, and postoperative histopathological results in patients with primary hyperparathyroidism (pHPT) due to parathyroid adenomas. PROCEDURES: This retrospective study was conducted in 52 patients with biochemically proven pHPT. [F]FCh-PET parameters (maximum standardized uptake value: SUV in early phase (after 2 min) and late phase (after 50 min), metabolic volume, and adenoma-to-background ratio (ABR), preoperative laboratory results (PTH and serum calcium concentration), and postoperative histopathology (location, size, volume, and weight of adenoma) were assessed. Relationship of PET parameters, laboratory parameters, and histopathological parameters was assessed using the Mann-Whitney U test and Spearman correlation coefficient. MRI characteristics of parathyroid adenomas were also analyzed. RESULTS: The majority of patients underwent a PET/MR scan, 42 patients (80.7 %); 10 patients (19.3 %) underwent PET/CT. We found a strong positive correlation between late-phase SUV and preoperative PTH level (r = 0.768, p < 0.001) and between late-phase ABR and preoperative PTH level (r = 0.680, p < 0.001). The surgical specimen volume was positively correlated with the PET/MR lesion volume (r = 0.659, p < 0.001). No significant association was observed between other [F]FCh-PET parameters, laboratory parameters, and histopathological findings. Cystic adenomas were larger than non-cystic adenomas (p = 0.048). CONCLUSIONS: [F]FCh uptake of parathyroid adenomas is strongly correlated with preoperative PTH serum concentration. Therefore, the preoperative PTH level might potentially be able to predict success of [F]FCh-PET imaging in hyperparathyroidism, with higher lesion-to-background ratios being expected in patients with high PTH. PET/MR is accurate in estimating the volume of parathyroid adenomas